Rockwell Medical Inc. Daily Stock Analysis

Daily Stock Analysis, RMTI, Rockwell Medical Inc, priceseries

Rockwell Medical Inc. Daily Stock Analysis
Stock Information
Open
0.32
Close
0.31
High
0.32
Low
0.30
Previous Close
0.32
Daily Price Gain
-0.01
YTD High
0.65
YTD High Date
Jan 13, 2022
YTD Low
0.30
YTD Low Date
Mar 7, 2022
YTD Price Change
-0.14
YTD Gain
-31.11%
52 Week High
1.54
52 Week High Date
Mar 17, 2021
52 Week Low
0.30
52 Week Low Date
Mar 7, 2022
52 Week Price Change
-0.92
52 Week Gain
-74.80%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Apr 17. 2017
6.61
May 3. 2017
8.06
12 Trading Days
21.92%
Link
LONG
Sep 15. 2017
6.43
Oct 5. 2017
7.81
14 Trading Days
21.40%
Link
LONG
Mar 7. 2018
5.97
Mar 15. 2018
6.27
6 Trading Days
5.02%
Link
LONG
Aug 6. 2018
4.25
Aug 15. 2018
4.47
7 Trading Days
5.25%
Link
LONG
Feb 6. 2019
3.27
Mar 14. 2019
4.79
25 Trading Days
46.61%
Link
LONG
Mar 15. 2019
5.21
Mar 25. 2019
5.77
6 Trading Days
10.73%
Link
LONG
Sep 4. 2019
2.51
Sep 24. 2019
3.15
14 Trading Days
25.46%
Link
LONG
Feb 14. 2020
2.54
Feb 27. 2020
2.83
8 Trading Days
11.46%
Link
LONG
Mar 24. 2020
2.45
Mar 27. 2020
2.73
3 Trading Days
11.22%
Link
LONG
Apr 8. 2020
2.12
Apr 22. 2020
2.36
9 Trading Days
11.35%
Link
LONG
Jan 11. 2021
1.12
Jan 27. 2021
1.28
11 Trading Days
14.62%
Link
LONG
Feb 3. 2021
1.29
Feb 18. 2021
1.56
10 Trading Days
20.81%
Link
Company Information
Stock Symbol
RMTI
Exchange
NasdaqGM
Company URL
http://www.rockwellmed.com
Company Phone
2489609009
CEO
Robert L. Chioini
Headquarters
Michigan
Business Address
30142 S WIXOM RD, WIXOM, MI 48393
Sector
Equity
Industry Category
Drugs
Industry Group
Drug Manufacturers - Major
CIK
0001041024
About

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the targeting of end-stage renal disease and chronic kidney disease and manufactures innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. Its dialysis products include Triferic, Calcitriol Vitamin D Injection, Hemodialysis Concentrates, CitraPure, Dri-Sate, and ancillary products. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Wixom, MI.

Description

Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. It offers products and services for the treatment of end-stage renal disease, chronic kidney disease, iron deficiency, secondary hyperparathyroidism, and hemodialysis. The company's lead drug is Triferic, an iron maintenance therapy that replaces the iron lost by patients during hemodialysis treatment via dialysate. It also provides Calcitriol, a generic active vitamin D injection, which is indicated for the treatment of secondary hyperparathyroidism in dialysis patients. In addition, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, Renalpure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubings, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Its concentrated dialysate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. The company's targets customers include senior and operating management of dialysis companies, dialysis service providers, nephrologists, clinic administrators, nurses, medical directors, and technical and purchasing personnel. Rockwell Medical, Inc. was founded in 1995 and is based in Wixom, Michigan.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading